View in EDS

Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.

Saved in:
Bibliographic Details
Title: Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.
Authors: Lewis JH; Department of Gastroenterology and Hepatology, Georgetown University Medical Center, Washington, DC, USA. lewisjh9205@gmail.com., Andrade RJ; Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain., Larrey D; Liver Unit, Saint-Eloi Hospital, Montpellier School of Medicine, Montpellier, France., Horsmans Y; Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc et Institut de Recherche Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium., Anderson RA; Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Trajanovic M; Bayer US LLC, Whippany, NJ, USA., Groettrup-Wolfers E; Bayer AG, Berlin, Germany., Zuurman L; Bayer CC, Basel, Switzerland.
Source: Drug safety [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 985-1002. Date of Electronic Publication: 2026 Mar 18.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41849128
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lewis+JH%22">Lewis JH</searchLink>; Department of Gastroenterology and Hepatology, Georgetown University Medical Center, Washington, DC, USA. lewisjh9205@gmail.com.<br /><searchLink fieldCode="AU" term="%22Andrade+RJ%22">Andrade RJ</searchLink>; Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Larrey+D%22">Larrey D</searchLink>; Liver Unit, Saint-Eloi Hospital, Montpellier School of Medicine, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Horsmans+Y%22">Horsmans Y</searchLink>; Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc et Institut de Recherche Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Anderson+RA%22">Anderson RA</searchLink>; Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Trajanovic+M%22">Trajanovic M</searchLink>; Bayer US LLC, Whippany, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Groettrup-Wolfers+E%22">Groettrup-Wolfers E</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Zuurman+L%22">Zuurman L</searchLink>; Bayer CC, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 985-1002. <i>Date of Electronic Publication: </i>2026 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41849128
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-026-01663-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 985
    Titles:
      – TitleFull: Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lewis JH
      – PersonEntity:
          Name:
            NameFull: Andrade RJ
      – PersonEntity:
          Name:
            NameFull: Larrey D
      – PersonEntity:
          Name:
            NameFull: Horsmans Y
      – PersonEntity:
          Name:
            NameFull: Anderson RA
      – PersonEntity:
          Name:
            NameFull: Trajanovic M
      – PersonEntity:
          Name:
            NameFull: Groettrup-Wolfers E
      – PersonEntity:
          Name:
            NameFull: Zuurman L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Numbering:
            – Type: volume
              Value: 49
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1